These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 74239)

  • 1. Pemphigus-like antibodies in bullous pemphigoid.
    Heine KG; Kumar A; Jordon RE
    Arch Dermatol; 1977 Dec; 113(12):1693-5. PubMed ID: 74239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
    Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
    Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
    Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
    J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study on 70 human embryos concerning the epidermal binding of pemphigus and pemphigoid antibodies.
    Varelzidis A; Tosca A; Coumantakis E; Nicolis G; Hatzis J; Papavasiliou S; Stratigos J
    Acta Derm Venereol; 1980; 60(2):129-33. PubMed ID: 6155018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunology of bullous diseases (pemphigus vulgaris and bullous pemphigus)].
    Diaz-Pérez JL
    Med Cutan Ibero Lat Am; 1976; 4(4):271-80. PubMed ID: 798081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus and pemphigoid: dermatologic examples of type II immune reactivity.
    Sams WM
    Ann Allergy; 1976 Oct; 37(4):255-63. PubMed ID: 791025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of antibody determination in the diagnosis of pemphigus and pemphigoid in the oral cavity using the indirect immunofluorescence method].
    Drízhal I; Nozicka Z; Rozsívalová V
    Cesk Stomatol; 1981 Mar; 81(2):94-9. PubMed ID: 7013995
    [No Abstract]   [Full Text] [Related]  

  • 8. Coexistence of bullous pemphigoid and systemic lupus erythematosus.
    Kumar V; Binder WL; Schotland E; Beutner EH; Chorzelski TP
    Arch Dermatol; 1978 Aug; 114(8):1187-90. PubMed ID: 354534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stimulation of autoantibody formation in pemphigoid due to proteolytic enzymes?].
    Remy W; Bockendahl H; Stüttgen G
    Hautarzt; 1976 Jul; 27(7):344-6. PubMed ID: 783086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized pemphigoid simulating dyshidrosiform dermatitis.
    Levine N; Freilich A; Barland P
    Arch Dermatol; 1979 Mar; 115(3):320-1. PubMed ID: 373634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of the biotin-avidin system to the study of autoimmune bullous diseases: immunofluorescence method using biotinylated-pemphigus and -pemphigoid antibodies and fluoresceinated avidin].
    Muramatsu T; Sakamoto K; Ikeda S
    Nihon Hifuka Gakkai Zasshi; 1988 Sep; 98(10):977-80. PubMed ID: 3065537
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ; Patel H; Diaz LA
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic aspects of bullous diseases.
    Safai B
    Pahlavi Med J; 1977 Jan; 8(1):106-32. PubMed ID: 319409
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunofluorescence studies of pemphigus and pemphigoid in Singapore.
    Tan T; Ratnam KV
    Ann Acad Med Singap; 1983 Jan; 12(1):13-8. PubMed ID: 6344738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillamine-induced bullous pemphigoid with pemphigus-like antibodies.
    Rasmussen HB; Jepsen LV; Brandrup F
    J Cutan Pathol; 1989 Jun; 16(3):154-7. PubMed ID: 2671069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cicatricial pemphigoid of Brunsting-Perry. Immunofluorescent studies.
    Michel B; Bean SF; Chorzelski T; Fedele CF
    Arch Dermatol; 1977 Oct; 113(10):1403-5. PubMed ID: 334084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescent follow-up studies in patients with bullous dermatoses.
    Remy W; Bockendahl H; Stüttgen G
    Acta Derm Venereol; 1975; 55(2):117-20. PubMed ID: 48314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.
    Sugi T; Hashimoto T; Hibi T; Nishikawa T
    J Clin Invest; 1989 Oct; 84(4):1050-5. PubMed ID: 2551921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous dermatosis and myeloma. Monoclonal anticytoplasmic antibody activity.
    Vincendeau P; Claudy A; Thivolet J; Tessier R; Texier L
    Arch Dermatol; 1980 Jun; 116(6):681-2. PubMed ID: 6990873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.